Fecal microbiota transplantation has gained growing scientific attention in numerous research areas, thanks to the increasing evidence supporting its effectiveness. In this review, we summarize the most relevant updates in the field of FMT published in the last year, covering various clinical areas, including Clostridioides difficile infection, inflammatory bowel disease, irritable bowel syndrome, diabetes, metabolic syndrome, and liver disease.